Nuclear Medicine

Prof. Dr. Tamer Özülker

Doctor and researcher İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi İstanbul
Thyroid Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNuclear Medicinesaglik.gov.trFrom source
  • Institutionİstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Area of workThyroid NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications61 publicationsOpenAlex, ORCID, Europe PMCFrom source
  • ORCID0000-0001-9521-683XORCIDFrom source
  • Last synchronised5 November 2026 08:55https://cemiltascioglush.saglik.gov.tr/TR-1563433/doktorlarimiz.html#tamer-ozulkersaglik.gov.tr

Scientific work

Publications on Thyroid Neoplasms

61 publications

  1. The effect of digital PET/CT and reconstruction algorithms on semi-quantitative values and Deauville scoring in patients with lymphoma.

    PubMed, 2025

    DOI 10.1967/s002449912904 PMID 41389257 Source: OpenAlex

  2. Is There Novel 18F-FDG Biodistribution in the Digital PET/CT Era? A Real-World Data Analysis

    Cancer Biotherapy and Radiopharmaceuticals, 2025

    DOI 10.1089/cbr.2024.0226 PMID 39866138 Source: ORCID

  3. The effect of reconstruction algorithms on semi-quantitative measurements in 18F-FDG PET/CT imaging.

    PubMed, 2024

    DOI 10.1967/s002449912721 PMID 39097805 2 citations (OpenAlex) Source: OpenAlex

  4. Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer

    Molecular imaging and radionuclide therapy, 2023

    DOI 10.4274/mirt.galenos.2022.05826 PMID 37337764 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  5. Meningioma Mimicking Bone Metastasis in Breast Cancer

    Molecular Imaging and Radionuclide Therapy, 2023

    DOI 10.4274/mirt.galenos.2022.31032 PMID 37337873 Open-access full textSource: ORCID

  6. Isolated Castrate-resistant Prostate Cancer Metastasis to Both Adrenal Glands Detected on 68Ga PSMA PET/CT

    Molecular imaging and radionuclide therapy, 2023

    DOI 10.4274/mirt.galenos.2023.03780 PMID 37870375 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  7. How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA

    Nuclear Medicine Communications, 2023

    DOI 10.1097/mnm.0000000000001722 PMID 37334538 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  8. Prevalence and Clinical Significance of Incidental Focal 18F-FDG Uptake in Colon on PET/CT Imaging

    Molecular Imaging and Radionuclide Therapy, 2022

    DOI 10.4274/mirt.galenos.2022.38247 PMID 35770960 6 citations (Europe PMC) Open-access full textSource: ORCID

  9. Contribution of Lower Extremity 68Ga PSMA PET/CT Imaging to Diagnosis and Treatment in Prostate Cancer

    European Archives of Medical Research, 2022

    DOI 10.4274/eamr.galenos.2021.50251 Open-access full textSource: OpenAlex

  10. Current Imaging in Metastatic Bone Diseases: Does PET Replace Bone Scintigraphy

    Nuclear Medicine Seminars, 2022

    DOI 10.4274/nts.galenos.2022.0010 Open-access full textSource: OpenAlex

View all 61 publications